Multimodal perioperative pain protocol 2 to the implementation of the pain protocol had a length of stay 1.26 times longer than patients undergoing laparotomy during the postimplementation period (p<0.01). For the more complex surgical patients who received the multimodal pain regimen (those with stage II-IV disease who underwent bowel resection), this translated into a reduction in length of hospital stay of 1.73 days when compared to the matched cohort. There was a significant reduction in average pain scale score on post-operative day zero from 4.49 to 3.63 (p=0.02) and an overall reduction of morphine equivalents used between the two groups on post-operative days 0-2, although this did not reach statistical significance.
Adverse outcomes between groups, including ileus, delirium, renal failure and re-admission, were similar.
Conclusions: Implementation of a multimodal perioperative pain regimen in patients undergoing gynecologic oncology laparotomy was associated with a significant reduction of length of hospital stay and improved pain scores without increased complications. Even in the absence of a complete Enhanced Recovery in Surgery Protocol, a multimodal perioperative pain regimen has the potential to shorten hospital stay and improve patient perceived pain.
Learning Objectives: Implementation of a multimodal perioperative pain regimen in gynecologic oncology laparotomy patients has been shown to reduce length of post-operative hospital stay and decrease patient perceived pain on POD 0. 
